Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 400

Similar articles for PubMed (Select 23345948)

1.

Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.

Hosokawa T, Kurosaki M, Tsuchiya K, Matsuda S, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Nakata T, Nishimura T, Suzuki S, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Izumi N.

World J Gastroenterol. 2013 Jan 14;19(2):249-57. doi: 10.3748/wjg.v19.i2.249.

2.

Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C.

Yamanaka Y, Shiraki K, Miyashita K, Inoue T, Kawakita T, Yamaguchi Y, Saitou Y, Yamamoto N, Nakano T, Nakatsuka A, Yamakado K, Takeda K.

World J Gastroenterol. 2005 Apr 14;11(14):2174-8.

3.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91. Epub 2007 Sep 15.

PMID:
17874276
4.

Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.

Abe H, Aida Y, Ishiguro H, Yoshizawa K, Miyazaki T, Itagaki M, Sutoh S, Aizawa Y.

World J Gastroenterol. 2013 Jan 7;19(1):78-85. doi: 10.3748/wjg.v19.i1.78.

5.

Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.

Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C.

J Gastrointest Surg. 2012 Feb;16(2):301-11; discussion 311. doi: 10.1007/s11605-011-1745-x. Epub 2011 Nov 18.

PMID:
22095524
6.

Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.

Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI.

Cardiovasc Intervent Radiol. 2014 Jun;37(3):705-15. doi: 10.1007/s00270-013-0708-x. Epub 2013 Aug 3.

PMID:
23912493
7.

Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.

Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.

Oncology. 2007;72 Suppl 1:98-103. Epub 2007 Dec 13.

PMID:
18087189
8.

Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.

Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD, Wu JC.

J Clin Gastroenterol. 2012 Jan;46(1):62-70. doi: 10.1097/MCG.0b013e31822b36cc.

PMID:
21934530
9.

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.

Jpn J Clin Oncol. 2007 Sep;37(9):658-72. Epub 2007 Aug 31.

10.

Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.

Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI.

Radiology. 2014 Mar;270(3):900-9. doi: 10.1148/radiol.13130940. Epub 2013 Oct 30.

PMID:
24475823
11.

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC.

Ann Hepatol. 2013 Mar-Apr;12(2):263-73.

PMID:
23396738
12.

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K.

Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578. doi: 10.1038/ajg.2011.425. Epub 2011 Dec 13.

13.

Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.

Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, Tatsumi C, Minami Y, Ueshima K, Fukunaga T, Haji S.

Dig Dis. 2007;25(4):303-9.

PMID:
17960064
14.

Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.

Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RS, Diniz MA, Alves VA, D'Albuquerque LA, Carrilho FJ.

World J Gastroenterol. 2014 Feb 14;20(6):1585-93. doi: 10.3748/wjg.v20.i6.1585.

15.

Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation.

Izumi N, Asahina Y, Noguchi O, Uchihara M, Kanazawa N, Itakura J, Himeno Y, Miyake S, Sakai T, Enomoto N.

Cancer. 2001 Mar 1;91(5):949-56.

PMID:
11251946
16.

Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.

Toshikuni N, Takuma Y, Goto T, Yamamoto H.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2361-6. doi: 10.5754/hge12934.

PMID:
23169175
17.

Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.

Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.

J Gastroenterol Hepatol. 2010 Mar;25(3):597-604. doi: 10.1111/j.1440-1746.2009.06125.x. Epub 2010 Jan 14.

PMID:
20074153
18.

Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.

Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS.

Liver Int. 2013 Jul;33(6):884-93. doi: 10.1111/liv.12132. Epub 2013 Mar 5.

PMID:
23461618
19.

Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.

Tsuchiya K, Asahina Y, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Kurosaki M, Enomoto N, Izumi N.

Liver Transpl. 2014 Mar;20(3):291-7.

PMID:
24734314
20.

Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis.

Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Kumada H.

J Gastroenterol Hepatol. 2008 Nov;23(11):1739-46. doi: 10.1111/j.1440-1746.2008.05436.x. Epub 2008 Aug 17.

PMID:
18713301
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk